Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06216548 · ClinicalTrials.gov registry record · NA
E-PRIME For Children With Medical Complexity
A NA study of Children With Medical Complexity, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 909
- Enrollment target
- 1
- Study location
NCT06216548: Recruiting NA study of Children With Medical Complexity, sponsored by Wake Forest University Health Sciences.
NCT06216548 is a NA study of Children With Medical Complexity that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 909 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06216548, a NA study of Children With Medical Complexity, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 909 participants
- Enrollment target
- 1
- Study location
Study Summary
Children with medical complexity (CMC) have very high needs for health and support services. CMC have very rare diseases that involve multiple organ systems. As a result, all CMC have multiple chronic conditions and need care from many specialists and services. While there are important benefits to the child and family in living at home, the continuing need for complex medical care places a profound burden on caregivers. Telehealth has long been considered a potential solution to barriers in access to care for children. The purpose of this research is to test whether telehealth can help pediatric primary care providers (PCPs) as they treat, monitor, and manage children with medical complexity (CMC). Additionally, it is to reduce caregiver and child burden as well as improve care coordination between multiple providers.
Primary Outcome
Number of hospital days + ER visit days + number of in-person appointments / child year
Conditions Studied
Interventions
- OTHER Usual Care and Enhanced Primary Care
- OTHER Enhanced Primary Care
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 909 participants |
| Start Date | 2024-06-19 |
| Est. Completion | 2028-04 |
| Phase | NA |
What NCT06216548 shows while recruiting
NCT06216548 is an interventional study that assigns participants to a tested intervention. The registered 909 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Children With Medical Complexity appearing as the primary indexed condition, and to 2 interventions - of which Usual Care and Enhanced Primary Care is the first listed.
NCT06216548 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06216548 about?
NCT06216548 is a clinical study titled "E-PRIME For Children With Medical Complexity". Children with medical complexity (CMC) have very high needs for health and support services. CMC have very rare diseases that involve multiple organ systems. As a result, all CMC have multiple chronic conditions and need care from many specialists and services. While there are important benefits to ...
What is the current status of trial NCT06216548?
This trial is currently recruiting. It is a NA study. The enrollment target is 909 participants. The study started on 2024-06-19. Estimated completion is 2028-04.
What conditions does trial NCT06216548 study?
This clinical trial studies the following conditions: Children With Medical Complexity.
What interventions are being tested in trial NCT06216548?
The interventions under investigation include: Usual Care and Enhanced Primary Care (OTHER), Enhanced Primary Care (OTHER).
Who is sponsoring clinical trial NCT06216548?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06216548 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Children With Medical Complexity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06216548's enrollment target sits among peer trials
909 124th of 2000 higher than 1,877 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05658497 · 908 participants
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
- NCT06131840 · 914 participants · Phase 1
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- NCT05769777 · 901 participants · Phase 2
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
- NCT05739955 · 918 participants · NA
Impact of Enhanced Daily Disinfection on Environmental Contamination in Hospital Rooms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI